Streetbeat News

Analyst Ratings

CHDN

Wells Fargo analyst Daniel Politzer has maintained an Overweight rating on Churchill Downs (NASDAQ:CHDN) but lowered the price target from $155 to $150.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:37 pm

OKTA

JMP Securities analyst Trevor Walsh has reiterated a Market Outperform rating on Okta (NASDAQ:OKTA) and maintained a $110 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:37 pm

CZR

Wells Fargo analyst Daniel Politzer has maintained an Overweight rating on Caesars Entertainment (NASDAQ:CZR) but lowered the price target from $74 to $73.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:36 pm

CYBR

JMP Securities analyst Trevor Walsh has reiterated a Market Outperform rating on CyberArk Software (NASDAQ:CYBR) and maintained a $195 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:35 pm

BYD

Wells Fargo analyst Daniel Politzer maintains an Overweight rating on Boyd Gaming (NYSE:BYD) and raises the price target from $82 to $83.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:35 pm

CRWD

JMP Securities analyst Trevor Walsh has reiterated a Market Outperform rating on CrowdStrike Holdings (NASDAQ:CRWD) and maintained a price target of $235.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:34 pm

SURG

SurgePays, Inc. (NASDAQ:SURG) has responded to a recent report containing errors and misleading content, stating it is a deliberate attempt to undermine the company's work. The company confirmed its compliance with the Affordable Connectivity Program and stated that its accounting records are accurate. The company expects to report a net income of over $6 million in the second quarter.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 12:33 pm

XPO

Goldman Sachs analyst Jordan Alliger maintains a Buy rating on XPO Logistics (NYSE:XPO) and raises the price target from $49 to $56.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:26 pm

PGR

Progressive's Q2 earnings per share (EPS) of $0.57 missed the analyst consensus estimate of $0.87 by 34.48%, a 48.18% decrease from the same period last year. Net premiums written of $14.72 billion also missed the estimate of $14.98 billion by 1.74%, though this is a 21.17% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:26 pm

IMAX

Benchmark analyst Mike Hickey has reiterated a 'Buy' rating on Imax (NYSE:IMAX) and maintained a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:26 pm